Daniel Daniele practises in all areas of intellectual property law, including copyright, trade‑marks and patents. Mr. Daniele is also a member of the Supreme Court of Canada and appellate advocacy practice team and the recall and crisis management practice team.
Mr. Daniele has particular experience in the area of pharmaceutical patent litigation. He has acted for innovative pharmaceutical companies in proceedings under the Patented Medicines (Notice of Compliance) Regulations, patent infringement actions, patent impeachment actions, section 8 damages actions and patent infringement damages actions.
Prior to joining our Toronto office, Mr. Daniele worked at another national law firm as a summer student in 2009. He then served as a judicial clerk to the Justices of the Court of Appeal for Ontario from 2010‑2011.
In law school, Mr. Daniele participated in a variety of advocacy competitions and was awarded first place in the Hicks Morley Labour Law Moot. During his studies, he worked as both a research and teaching assistant and volunteered with the Western Business Law Clinic. In the fall of 2009, he completed an exchange term at Hong Kong University. Mr. Daniele currently holds a part‑time faculty of law appointment at Western University.
Mr. Daniele’s undergraduate degree focused on the application of engineering principles and design concepts to medicine and biology.
Year of call
New York 2011
J.D., Western University, 2010
B.A.Sc., Engineering Science, University of Toronto, 2006
Rankings and recognitions
- Law Society of Upper Canada Prize (awarded to top 15 students in graduating class)
- J.S.D. Tory Writing Award
- Scotiabank Award for highest standing in trusts
- Shibley Righton LLP Award for highest standing in income taxation
Memberships and activities
- Canadian Bar Association
- Ontario Bar Association
- Toronto Intellectual Property Group
- American Bar Association
- New York State Bar Association
On May 5, 2015, the Court of Appeal for Ontario dismissed Apotex’s appeal from the Ontario Divisional Court, which struck out Apotex’s claim..
May 11, 2015
On January 23, 2015, the Federal Court released its public reasons for Judgment granting Eli Lilly and Company and Eli Lilly Canada patent infringement damages..
January 30, 2015
Norton Rose's Patrick Kierans, Richard Wagner and Daniel Daniele explore the healthcare implications if Canada signs up to Europe's drug patent demand.
November 30, 2012